Chinese medicine need to tap the potential and advantages

Recently, the reporter interviewed in New York to attend the 50th session of the "American tumor radiation therapy school" and "evidence-based radiation oncology therapeutics," the book's first Chinese-American scholars, National University of Singapore medical professor in the Department of Medicine, National University Cancer Center radiation oncology specialist, a subsidiary of Shanghai Fudan University Cancer Hospital Professor Dr. Lu Jiade. As young as 38-year-old Professor Lu Jiade results is a big success, with the United States from his tumor Therapy radiology top Luther
Brady, a professor co-editor of "evidence-based Radiation Therapy Oncology" (Radiation Oncology: An Evidence-Based
Approach) of the book has become in the area of the world's major academic works. Professor Lu Jiade to reporters about the course of their struggle for the future and the idea of the cause, he is a famous phrase "I hope that the treatment of cancer as a result of my efforts to change."
We are focused on the topic of China's medical cause of how to catch up with international advanced level of technology, the reporters would like to hear for many years overseas in the internationally renowned medical expert opinions.

Professor Lu Jiade told reporters that a long time, Europe and the United States in the field of biomedical research has been in a dominant position in Asia is more in a subordinate status, it is undeniable that the majority of biomedical research professionals with European and American scientific research there is a big country more Gap. However, in the Asia research in the field of medical science has its own unique advantages, including China, many countries, not only has the number of patient substantial enough to launch a large number of clinical studies, researchers and resources, but also Europe and the United States has unmatched Advantages. At the same domestic medical institutions in co-operation, I found that younger colleagues not only has the talent, but hard to learn, in cooperation with them, I also felt great to explore their desire to find. Their knowledge of researchers to explore the desire the momentum generated far more than any external forces, which may in the future in Asia as an international leading oncology centers the biggest driving force.

Professor Lu Jiade told reporters that many Asian countries such as China, Singapore and other countries on biomedical research in the field of direct support is unprecedented, and most of these advantages in Europe and the United States is not the experience. If we can make full use of various advantages, such as Europe and the United States in medical education research, development and management advantages of combining the advantages of Asian countries themselves, to obtain the results of research and medical contributions will be very substantial.

Professor Lu Jiade said: We tend to believe that the United States is conducting oncology research and academic development of the best land, in fact, Asia in particular China in the field of oncology development, as opposed to the advantages of Europe and the United States is very clear. I received a degree in the United States, the United States has also worked for many years, but in recent years to return to Asia's development. At the same exchanges in China, I found that the patients in the study of resources, human resources, China has the advantage of the many countries can not be compared. Indeed, in Asia in the field of oncology basic and clinical research behind the United States, the problem lies in the idea of learning and research and methodological differences, if there is no difference, in fact, Asia in particular China in the biomedical field advantage more . For example, cancer snuff high incidence of the disease in Southeast Asia, most recently, I was just published in the editor-in-chief of "evidence-based Radiation Therapy Oncology", the world's largest science and technology publishing house Springer Publishing Company, editor-in-chief invited me to participate in "snuff cancer diagnosis and treatment of learning" If there is no Asian snuff in the diagnosis and treatment of cancer and research on the many advantages, we will not be able to complete the academic program. One could even say that the years I have achieved some results, mainly in the United States to the development of the medical academic and research ideas and methods to sum up, with resources in Asia on the advantages of organically integrated up.

On how to improve the status of Asia in medical research, said Professor Lu Jiade, with the strengthening of European and American counterparts the exchange of advanced research institutions is very important, but to really learn advanced concepts and methods and learn more than just book knowledge, the exchange must be Is substantial. Although many of the domestic institutions with frequent exchanges of Europe and the United States, but only to send personnel to participate in academic conferences abroad, or foreign experts and scholars to visit some of the lectures or short-term courses are to stay in the non-substantive exchange level. Scholars to exchange real productive, we must let the scholars have the opportunity to participate in the completion of research and academic projects, in the process of cooperation, not only to learn technical knowledge level of knowledge, but also through direct involvement and interaction opportunities To understand the concept and methodology of the level of knowledge. In other words, this exchange is the ultimate goal of learning research methods and ideas, and certainly not just the completion of a project. Book knowledge can be disseminated through lectures, and the idea is to be challenged myself can rely on to teach.

It is understood that the past few years, Professor Lu Jiade In addition to his outstanding academic achievements, he was training for other countries in Asia, particularly China, the oncology professionals, many of the efforts made. In 2003, in Singapore and China and his colleagues in the joint efforts of the National University of Singapore and Shanghai Cancer Center of Fudan University Cancer Hospital officially became sister hospital. Shanghai every year from young scholars in Singapore for one year of work and learning. And visits to other countries to study different is that the education of doctors here to have access to the Hospital Authority of Singapore temporary license to practice medicine, clinical practice can be carried out directly on the implementation of the treatment of cancer patients. Professor Lu Jiade also help the Chinese education officials issued a position in the international academic results and has achieved significant results.